Cosmo Pharmaceuticals is seeking to move its headquarters to Luxembourg as the Italian drug maker looks for a lower-tax environment, after a planned $2.7 billion merger with a U.S. company fell through.
from WSJ.com: US Business http://ift.tt/1tt7Un8
via IFTTT
from WSJ.com: US Business http://ift.tt/1tt7Un8
via IFTTT
No comments:
Post a Comment